ALS drug wins FDA approval despite questionable data
Acute respiratory illness due to EV-D68 increased in late summer 2022
30 September 2022Legal marijuana, but Uruguayans still prefer black market
30 September 2022ALS drug wins FDA approval despite questionable data
A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
